Horizon commences commercial launch of Rayos delayed-release tablets
Rayos is a proprietary delayed-release formulation of low-dose prednisone and is known as Lodotra outside the US. Horizon Pharma chairman, president and chief executive officer Timothy Walbert said
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.